½ÃÀ庸°í¼­
»óǰÄÚµå
1303566

¼¼°èÀÇ ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°, Ä¡·á À¯Çüº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Medical Linear Accelerator Market Size study & Forecast, by Product Type, By Treatment Type and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀåÀº 2022³â ¾à 31¾ï 7,845¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â 7.1% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á¿ë ¼±Çü °¡¼Ó±â(¸®´Ï¾î¾×ÅͶó°íµµ ÇÔ)´Â ¹æ»ç¼±Á¾¾çÇп¡¼­ ¾Ï Ä¡·á¿¡ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. °í¿¡³ÊÁö X¼±À̳ª ÀüÀÚºöÀ» »ý¼ºÇÏ´Â º¹ÀâÇÑ ±â°è·Î, °Ç°­ÇÑ ÁÖº¯ Á¶Á÷ÀÇ ÇÇÆøÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¾Ï Á¾¾ç¿¡ Á¤È®ÇÑ ¼±·®ÀÇ ¹æ»ç¼±À» Á¶»çÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀåÀº ¾Ï °ü·Ã »ç·ÊÀÇ Áõ°¡¿Í ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¼±Çü °¡¼Ó±â´Â ¿ÜºÎ ºö ¹æ»ç¼± Ä¡·á, °­µµ º¯Á¶ ¹æ»ç¼± Ä¡·á, Á¤À§Àû ¹æ»ç¼± Ä¡·á, Á¤À§Àû ¹æ»ç¼± ¼ö¼ú µî ´Ù¾çÇÑ ¹æ»ç¼± Ä¡·á ±â¼ú¿¡ »ç¿ëµË´Ï´Ù. ¾Ï Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, Çö´ë ¹æ»ç¼± Á¾¾çÇп¡¼­ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¾ÏÀº Àü ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î 2020³â¿¡´Â ¾à 1,000¸¸ ¸í, Áï 6¸í Áß 1¸íÀÌ ¾ÏÀ¸·Î »ç¸ÁÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ¹Ì±¹ ¾ÏÇÐȸ¿¡ µû¸£¸é, 2022³â ¹Ì±¹¿¡¼­ 190¸¸ ¸íÀÇ ¾Ï ȯÀÚ°¡ »õ·Î Áø´Ü¹Þ°í 60¸¸ 9360¸íÀÌ »ç¸ÁÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. °ø°£À» À̲ô´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ä¼Ò´Â ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ¹ü¹Ìº¸°Ç±â±¸(Pan American Health Organization)¿¡ µû¸£¸é 2019³â Áö¿ª Àüü ½Å°æÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â 533,172¸íÀ¸·Î ³²¼ºÀÇ 40%, ¿©¼ºÀÇ 60%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¶ÇÇÑ 2019³â ¹Ì±¹ÀÇ ½Å°æ°è Áúȯ ó¹æ¾à ½ÃÀåÀº ¾à 200¾ï ´Þ·¯¿¡ ´ÞÇÕ´Ï´Ù. ¶ÇÇÑ Á¦Ç° °³¹ßÀÇ ¹ßÀü°ú ´Ù¾çÇÑ Áúº´ÀÇ À¯º´·ü Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå Àü¸ÁÀ» âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª ÀÇ·á¿ë ¼±Çü°¡¼Ó±âÀÇ ³ôÀº ºñ¿ëÀº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, ±âŸ Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í ÀÌ Áö¿ªÀÇ ±â¼ú ¹ßÀüÀÇ Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. Statista¿¡ µû¸£¸é 2023³â ¼¼°è ÀÇ·á ±â¼ú ½ÃÀå¿¡¼­ °¡Àå ¸¹Àº ¼öÀÍÀ» âÃâÇÏ´Â Áö¿ªÀº ¹Ì±¹À¸·Î 1,998¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ¶ÇÇÑ ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¸®Àû È®Àå, Á¤ºÎ ±â°üÀÇ ½ÃÀå ÁøÀÔ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
    • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå : Áö¿ªº°, 2020-2030³â
    • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå : Á¦Ç° À¯Çüº°, 2020-2030³â
    • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå : Ä¡·á À¯Çüº°, 2020-2030³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»ç °¡Á¤

Á¦2Àå ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå ¿ªÇÐ

  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • ¾Ï °ü·Ã Áõ·Ê¼ö Áõ°¡
      • ½Å°æÁúȯ Áõ°¡
    • ½ÃÀå °úÁ¦
      • ÀÇ·á¿ë ¼±Çü °¡¼Ó±âÀÇ °íºñ¿ë
    • ½ÃÀå ±âȸ
      • Á¦Ç° °³¹ß Áøº¸
      • ´Ù¾çÇÑ Áúȯ À¯º´·ü Áõ°¡

Á¦4Àå ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : Á¦Ç° À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : Á¦Ç° À¯Çüº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : Á¦Ç° À¯Çüº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Àü¿ë ¸®´Ï¾î °¡¼Ó±â
    • ºñÀü¿ë ¸®´Ï¾î °¡¼Ó±â

Á¦6Àå ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : Ä¡·á À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : Ä¡·á À¯Çüº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ¼¼°è ½ÃÀå : Ä¡·á À¯Çüº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • °­µµ º¯Á¶ ¹æ»ç¼± Ä¡·á
    • üÀû º¯Á¶ ¾ÆÅ© Ä¡·á
    • ¿µ»ó À¯µµ ¹æ»ç¼± Ä¡·á
    • Á¤À§Ã¼ ¹æ»ç¼± Ä¡·á

Á¦7Àå ¼¼°èÀÇ ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå, Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç° À¯Çü ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • Ä¡·á À¯Çü ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á¿ë ¼±Çü °¡¼Ó±â ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Accuray Inc.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ÃÖ±ÙÀÇ µ¿Çâ
    • General Electric
    • Viewray Technologies, Inc.
    • Shinva Medical Instruments Co. Ltd.
    • Panacea Medical Technologies Pvt. Ltd.
    • Varian Medical Systems Inc.
    • Hitachi Ltd.
    • Shinva Medical Instrument Co. Ltd.
    • Mitsubishi Heavy Industries, Ltd.
    • Koninklijke Philips N.V.

Á¦9Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 23.08.03

Global Medical Linear Accelerator Market is valued at approximately USD 3178.45 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2023-2030. A medical linear accelerator, also known as a linac, is a type of medical equipment used in radiation oncology for the treatment of cancer. It is a complex machine that generates high-energy X-rays or electron beams, which are used to deliver precise doses of radiation to cancerous tumors while minimizing the exposure of healthy surrounding tissues. The Medical Linear Accelerator market is expanding because of factors such as rising number of cases related to cancer and increasing prevalence of neurological disorders.

Medical linear accelerators are used for a variety of radiation therapy techniques, including external beam radiation therapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery. They play a crucial role in the treatment of cancer and are an essential tool in modern radiation oncology. According to the World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. According to the American Society of Cancer in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Another important component driving space is increasing prevalence of neurological disorders. According to the Pan American Health Organization, in 2019, regionwide Neurological conditions account for 533,172 deaths, 40% in men, and 60% in women. In addition, in 2019, the prescription pharmaceuticals market in the United States for nervous system disorders is around USD 20 billion. Also, advancement in product development and growing prevalence of various diseases would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Medical Linear Accelerator stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Medical Linear Accelerator Market study include: Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in 2022 owing to the presence of key market players and rising technological advancement in the region. According to Statista, in the global medical technology market most revenue will be generated in the United States USD 199.80 billion in 2023. Furthermore, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, geographic expansion of key players, and active participation of government organizations in the market space.

Major market players included in this report are:

  • Accuray Inc.
  • General Electric
  • Viewray Technologies, Inc.
  • Shinva Medical Instruments Co. Ltd.
  • Panacea Medical Technologies Pvt. Ltd.
  • Varian Medical Systems Inc.
  • Hitachi Ltd.
  • Shinva Medical Instrument Co. Ltd.
  • Mitsubishi Heavy Industries, Ltd.
  • Koninklijke Philips N.V.

Recent Developments in the Market:

  • In June 2022, Accuray Incorporated and Limbus AI Inc collaborated to improve adaptive radiotherapy features by integrating Limbus' AI-driven auto contouring algorithms, allowing automated contouring to further streamline the treatment planning process.

Global Medical Linear Accelerator Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product Type, Treatment Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type

  • Dedicated Linear Accelerator
  • Non-Dedicated Linear Accelerator

By Treatment Type

  • Intensity Modulated Radiation Therapy
  • Volumetric Modulated Arc Therapy
  • Image Guided Radiation Therapy
  • Stereotactic Body Radiotherapy

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Medical Linear Accelerator Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Medical Linear Accelerator Market, by Product Type, 2020-2030 (USD Million)
    • 1.2.3. Medical Linear Accelerator Market, by Treatment Type, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Medical Linear Accelerator Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Medical Linear Accelerator Market Dynamics

  • 3.1. Medical Linear Accelerator Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising number of cases related to cancer
      • 3.1.1.2. Increasing prevalence of neurological disorders
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Medical Linear Accelerator
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancement in product development
      • 3.1.3.2. Growing prevalence of various diseases

Chapter 4. Global Medical Linear Accelerator Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Medical Linear Accelerator Market, by Product Type

  • 5.1. Market Snapshot
  • 5.2. Global Medical Linear Accelerator Market by Product Type, Performance - Potential Analysis
  • 5.3. Global Medical Linear Accelerator Market Estimates & Forecasts by Product Type 2020-2030 (USD Million)
  • 5.4. Medical Linear Accelerator Market, Sub Segment Analysis
    • 5.4.1. Dedicated Linear Accelerator
    • 5.4.2. Non-Dedicated Linear Accelerator

Chapter 6. Global Medical Linear Accelerator Market, by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Medical Linear Accelerator Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Medical Linear Accelerator Market Estimates & Forecasts by Treatment Type 2020-2030 (USD Million)
  • 6.4. Medical Linear Accelerator Market, Sub Segment Analysis
    • 6.4.1. Intensity Modulated Radiation Therapy
    • 6.4.2. Volumetric Modulated Arc Therapy
    • 6.4.3. Image Guided Radiation Therapy
    • 6.4.4. Stereotactic Body Radiotherapy

Chapter 7. Global Medical Linear Accelerator Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Medical Linear Accelerator Market, Regional Market Snapshot
  • 7.4. North America Medical Linear Accelerator Market
    • 7.4.1. U.S. Medical Linear Accelerator Market
      • 7.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Treatment Type breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Medical Linear Accelerator Market
  • 7.5. Europe Medical Linear Accelerator Market Snapshot
    • 7.5.1. U.K. Medical Linear Accelerator Market
    • 7.5.2. Germany Medical Linear Accelerator Market
    • 7.5.3. France Medical Linear Accelerator Market
    • 7.5.4. Spain Medical Linear Accelerator Market
    • 7.5.5. Italy Medical Linear Accelerator Market
    • 7.5.6. Rest of Europe Medical Linear Accelerator Market
  • 7.6. Asia-Pacific Medical Linear Accelerator Market Snapshot
    • 7.6.1. China Medical Linear Accelerator Market
    • 7.6.2. India Medical Linear Accelerator Market
    • 7.6.3. Japan Medical Linear Accelerator Market
    • 7.6.4. Australia Medical Linear Accelerator Market
    • 7.6.5. South Korea Medical Linear Accelerator Market
    • 7.6.6. Rest of Asia Pacific Medical Linear Accelerator Market
  • 7.7. Latin America Medical Linear Accelerator Market Snapshot
    • 7.7.1. Brazil Medical Linear Accelerator Market
    • 7.7.2. Mexico Medical Linear Accelerator Market
  • 7.8. Middle East & Africa Medical Linear Accelerator Market
    • 7.8.1. Saudi Arabia Medical Linear Accelerator Market
    • 7.8.2. South Africa Medical Linear Accelerator Market
    • 7.8.3. Rest of Middle East & Africa Medical Linear Accelerator Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Accuray Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. General Electric
    • 8.3.3. Viewray Technologies, Inc.
    • 8.3.4. Shinva Medical Instruments Co. Ltd.
    • 8.3.5. Panacea Medical Technologies Pvt. Ltd.
    • 8.3.6. Varian Medical Systems Inc.
    • 8.3.7. Hitachi Ltd.
    • 8.3.8. Shinva Medical Instrument Co. Ltd.
    • 8.3.9. Mitsubishi Heavy Industries, Ltd.
    • 8.3.10. Koninklijke Philips N.V.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦